ConductScience.org, home

Paper42467182

18F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers.

Imabayashi E and 5 others. Ann Nucl Med, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. 18F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers. Papers, record 42467182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42467182

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
18F-flortaucipir PET imaging: Biodistribution in the Japanese population and diagnostic accuracy by Japanese readers.
PubMed
Journal
Ann Nucl Med
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Imabayashi EEtsukohttps://orcid.org/0000-0003-1708-3618
2Morris AAmanda
3Iaccarino LLeonardo
4Arora AKAnupa K
5Kamiki EEriko
6Lu MMing

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbolinesMajor topic
Positron-Emission TomographyMajor topic
East Asian PeopleMajor topic
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Japan
Tissue Distribution

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Eli Lilly and CompanyEli Lilly and CompanyPubMed
Avid RadiopharmaceuticalsAvid RadiopharmaceuticalsPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03901092A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationDerived from the trialYesClinicalTrials.gov
NCT04474405Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsDerived from the trialYesClinicalTrials.gov

Download CSV of trials

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139776249Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.Alzheimers Dement2025https://conductscience.org/library/papers/39776249PubMed
226728162Human Radiation Dosimetry of [(18)F]AV-1451(T807) to Detect Tau Pathology.Mol Imaging Biol2016https://conductscience.org/library/papers/26728162PubMed
333986301Alzheimer disease.Nat Rev Dis Primers2021https://conductscience.org/library/papers/33986301PubMed
433573211Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/33573211PubMed
538733347Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy.Protein Cell2025https://conductscience.org/library/papers/38733347PubMed
6843571The measurement of observer agreement for categorical data.Biometrics1977https://conductscience.org/library/papers/843571PubMed
736855201Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression.Alzheimers Res Ther2023https://conductscience.org/library/papers/36855201PubMed
837748892Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies.Neurology2023https://conductscience.org/library/papers/37748892PubMed
941739230Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison.Acta Neuropathol2026https://conductscience.org/library/papers/41739230PubMed
1032338734Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.JAMA Neurol2020https://conductscience.org/library/papers/32338734PubMed
1135596745Monoamine oxidase binding not expected to significantly affect [18F]flortaucipir PET interpretation.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/35596745PubMed
1237459141Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.JAMA2023https://conductscience.org/library/papers/37459141PubMed
1329449700Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.Nat Rev Neurol2018https://conductscience.org/library/papers/29449700PubMed
1438934362Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.Alzheimers Dement2024https://conductscience.org/library/papers/38934362PubMed
1533587110
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials.
JAMA Neurol2021https://conductscience.org/library/papers/33587110PubMed
1638187878A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.Brain Commun2024https://conductscience.org/library/papers/38187878PubMed
1726505746Tau positron emission tomographic imaging in aging and early Alzheimer disease.Ann Neurol2016https://conductscience.org/library/papers/26505746PubMed
1823948934Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.J Alzheimers Dis2014https://conductscience.org/library/papers/23948934PubMed
1922265587National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.Alzheimers Dement2012https://conductscience.org/library/papers/22265587PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137

Source NCBI Gene

Download CSV of genes

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
FLORBETAPIRCHEMBL1908919Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1908919ChEMBL
FLORTAUCIPIR F 18CHEMBL3545253Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3545253ChEMBL
FLORTAUCIPIRCHEMBL3546271Derived from the trial1https://conductscience.org/library/drugs/CHEMBL3546271ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Cited by
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42467182

GET https://conductscience.org/api/papers/v1/42467182/authors